To navigate the complexities of sophisticated drug development and manufacturing, a fundamental shift toward AI-powered ...

Despite the slow trickle of updates on President Donald Trump’s proposed pharmaceutical import tariffs, drugmakers have ...

As the pharma sector braces for sector-specific tariffs from President Trump, what could the impact look like on supply ...

President Trump has threatened to impose pharma tariffs to encourage investment in U.S. manufacturing, but experts say there could be unintended consequences.

NIPTE continues its long-held mission to promote quality and availability of medicines in the US. MINNEAPOLIS, June 18, 2025 /PRNewswire/ -- The National Institute for Pharmaceutical Technology ...

Shift is expected to drive a sharp increase in generic drug launches, positioning Indian drugmakers for strong growth ...

Ben Simpfendorfer, Partner at Oliver Wyman, explains why having a multi-country manufacturing presence, including China, is ...

The Middle East life sciences market will grow to $36bn by 2028, driven by R&D investments, digital health adoption, and ...

Piramal Pharma Solutions is investing $90M to expand two of its U.S. facilities, adding commercial-scale manufacturing ...

President Donald Trump wants manufacturing jobs to return to the U.S., but it's not as simple as that, Virginia experts say ...

Indian pharma assertive to chalk out pathway for revised Schedule M compliance without compromise: Nandita Vijayasimha, Bengaluru Thursday, June 26, 2025, 08:00 Hrs [IST] In a glo ...